Adamis Pharmaceuticals GAAP EPS of -3.40
| ADMPDelisted Stock | USD 1.74 0.24 12.12% |
Slightly above 62% of Adamis Pharma's investor base is looking to short. The analysis of current outlook of investing in Adamis Pharma suggests that many traders are alarmed regarding Adamis Pharma's prospects. Adamis Pharma's investing sentiment overview a quick insight into current market opportunities from investing in Adamis Pharma. Many technical investors use Adamis Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Adamis |
Adamis Pharmaceuticals press release Q2 GAAP EPS of -3.40. Revenue of 6.95K Cash and cash equivalents as of June 30, 2023, were approximately 0.6 million.
Read at seekingalpha.com
 |
Adamis Pharma Fundamental Analysis
We analyze Adamis Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adamis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adamis Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Adamis Pharma is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Adamis Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adamis Pharma stock to make a market-neutral strategy. Peer analysis of Adamis Pharma could also be used in its relative valuation, which is a method of valuing Adamis Pharma by comparing valuation metrics with similar companies.
Peers
Adamis Pharma Related Equities
| EVOK | Evoke Pharma | 5.35 | ||||
| AQST | Aquestive Therapeutics | 0.96 | ||||
| ORGO | Organogenesis Holdings | 0.57 | ||||
| TLRY | Tilray | 3.42 | ||||
| LFCR | Lifecore Biomedical | 4.51 | ||||
| SHPH | Shuttle Pharmaceuticals | 6.12 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Adamis Stock
If you are still planning to invest in Adamis Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adamis Pharma's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |